martes, 5 de febrero de 2019

This small drug maker is taking on Allergan and Restasis

This small drug maker is taking on Allergan and Restasis

STAT
Each month, STAT Plus aims to bring our readers market-moving analysis of the biotech, pharma, and life sciences industries. Our team of veteran reporters — from Sharon Begley to Matthew Herper — help cut through the noise to bring you the most impactful headlines, and analysis of the people, policies, and scientific breakthroughs making waves in the industry.

This small Canadian drug maker is taking on Allergan and its best-selling eye drop medicine

No hay comentarios: